At Novocure, our mission is to extend survival for patients diagnosed with some of the most aggressive forms of cancer through the development of Tumor Treating Fields therapy. This quarter, we grew ...
Joining me today are Carsten Koerl, our CEO; and Craig Felenstein, our CFO. Carsten Koerl: Good morning, everyone, and thank you for joining us today. At the same time, our focus on efficiencies and ...
Alphabet previously killed a robotics project called Everyday Robots. Now it's saying goodbye to another one: an exoskeleton project called Skip.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback